Google
XTNT Stock Price & Analysis — Xtant Medical Holdings Inc (Healthcare >> Medical Devices)
XTNT FAQ
What is XTNT's P/E ratio?
Xtant Medical Holdings Inc (XTNT) currently trades at a P/E ratio of 12.44.
What is XTNT's ROE?
Xtant Medical Holdings Inc reports a Return on Equity (ROE) of 3.76%.
What is XTNT's dividend yield?
Xtant Medical Holdings Inc offers a dividend yield of 0.00%.
What is XTNT's Quality Score?
Our AI rates XTNT's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy XTNT?
Our AI Timing Score for XTNT is 1 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does XTNT belong to?
Xtant Medical Holdings Inc is classified under the Healthcare >> Medical Devices sector on the NYSE MKT exchange
XTNT AI Analysis Summary
Our AI summary for XTNT: Xtant Medical Holdings Inc (NYSE MKT), Healthcare >> Medical Devices sector. The stock currently trades at a P/E of 12.44, ROE of 3.76%, a dividend yield of 0.00%. Its financial Quality Score stands at 38/100 — fundamentals below the market average. The AI Timing Score is 1/100 — most technical signals do not support an entry at this point. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.
|
USD 0.44
Price
0.00
(0.96%)
Day Change
|
|
|---|
XTNT, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
Acceleration of ROE growth rate is below our criteria.
Historical ROE is relatively low
ROE is decreasing significantly
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Momentum indicators aligned on the daily timeframe
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
50% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 93 |
| Magic Formula Rank by ROA |
839
|
| Magic Formula Rank by ROE |
839
|
| Magic Formula Rank by ROIC |
267
|
| Price | 0.44 |
| PBV / Sector |
1.26 / 4.62
GOOD
|
| Earning Per Share | 0.01 |
| PE / Sector |
12.44 / 32.46
GOOD
|
| PEG or PE/Growth / Sector |
-0.01 / 0.50
|
| Average 1M Daily Value |
0.04 M
GREAT
|
| Average 1W Daily Value |
0.02 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
45% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-08-06 08:00:56 |
| Symbol | XTNT |
| Name | XTANT MEDICAL HOLDINGS INC |
| Sector | Healthcare >> Medical Devices |
| Market | NYSE MKT |
| Listed Shares | 140.26 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 61.13 / 20,302.66 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 664 Cruiser Lane, Belgrade, MT, United States, 59714
Phone: 406 388 0480
Website: https://xtantmedical.com
Employees: 151
Sector: Healthcare >> Medical Devices
Description: Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. It offers OsteoSponge, a natural scaffold for cellular in-growth; OsteoSelect DBM Putty, a moldable demineralized bone matrix; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated and terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor Pro, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, an aseptically processed and viable bone allograft; and nanOss products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also provides sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers cervical products comprising Spider cervical plating, Streamline OCT system, and CervAlign systems; thoracolumbar products, such as of Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation, and HPS 2.0 hybrid performance systems; Silex sacroiliac joint fusion systems; interbody products comprising Calix for cervical and thoracolumbar applications, Irix-C Cervical and Irix-A lumbar integrated dusion systems, and Fortilink implants; Contact ALP (Anterior Lumbar Plate) System; and interlaminar stabilization products, such as Coflex device for lumbar spinal stenosis; and CoFix implants for back and disc pain. The company is headquartered in Belgrade, Montana.
Analyst Ratings & Target Price
ME vs SECTOR Healthcare >> Medical Devices
Click a bubble to view stock details · Bubble size represents market capitalization share
